In terms of medical devices in the pharmaceutical sector, we still have a lot of regulations. Sometimes there is maybe too much regarding some issues; sometimes not enough on other issues. As for medical devices, the problem is that it's still a bit of the far west out there in terms of the regulatory process, both in the U.S. and Canada. With regard to the health technology assessment, we have very little capacity to really determine the value of these new medical devices.
You have this whole sector where the type of marketing you have in the pharmaceutical sector is also evident among the manufacturers of medical devices. You don't have the regulations to ensure that it's not going adrift. For this not to go adrift...the regulations in the pharmaceutical sector are at least embedding the practices. With medical devices, we're seeing weird stuff going on.
Maybe Steve Morgan could add to this. Basically, from what we see from the FDA and the reports out there, the problem of evaluating value for money for that and the marketing practices that are going on as well.... My understanding is that it's very problematic. I know that we're trying to beef up our understanding.